Literature DB >> 814528

Fucosidosis type 2.

B G Kousseff, N G Beratis, L Strauss, P W Brill, R E Rosenfield, B Kaplan, K Hirschhorn.   

Abstract

Two siblings, 9 and 4 1/2 years old, had alpha-L-fucosidase deficiency, angiokeratoma, progressive psychomotor retardation, neurologic signs, coarse facila features, and dysostosis multiplex. It appears that genetic heterogeneity is present in fucosidosis; there are at least two types. In type 1, patients have no vascular lesions, but have rapid psychomotor regression, severe and rapidly progressing neurologic signs, elevated sodium and chloride excretion in the sweat, and fatal outcome before the sixth year. In type 2, patients have angiokeratoma, milder psychomotor retardation and neurologic signs, longer survival, and normal salinity in the sweat. Quantitative studies on erythrocytes and in saliva disclosed severely increased expressions of Lea and Leb. Biopsies of skin and gingiva showed alterations as seen in angiokeratoma. There was also evidence of lysosomal storage in vascular endothelium, eccrine sweat gland epithelium, and fibroblasts of the skin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 814528

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  Identification of a mutation in the structural alpha-L-fucosidase gene in fucosidosis.

Authors:  P J Willems; J K Darby; R A DiCioccio; P Nakashima; C Eng; K A Kretz; L L Cavalli-Sforza; E M Shooter; J S O'Brien
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

Review 3.  CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Shanzhi Gu; Qing-Rong Liu
Journal:  J Psychopharmacol       Date:  2011-03-29       Impact factor: 4.153

Review 4.  Metabolic syndromes with dermatologic manifestations.

Authors:  M Irons; H L Levy
Journal:  Clin Rev Allergy       Date:  1986-02

5.  Restriction analysis of the structural alpha-L-fucosidase gene and its linkage to fucosidosis.

Authors:  J K Darby; P J Willems; P Nakashima; J Johnsen; R E Ferrell; E M Wijsman; D S Gerhard; N C Dracopoli; D Housman; J Henke
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

6.  Human and canine fucosidosis: a comparative lectin histochemistry study.

Authors:  J Alroy; A A Ucci; C D Warren
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Ultrastructural studies of type II fucosidosis.

Authors:  B Porfiri; R Ricci; D Seminara; G Segni
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

8.  Absence of alpha-fucosidase activity in two sisters showing a different phenotype.

Authors:  H Christomanou; D Beyer
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

9.  Fucosidosis: ultrastructural study of the eye in an adult.

Authors:  M Hoshino; T P O'Brien; J M McDonnell; Z C de la Cruz; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

10.  Morphological study of skin biopsy specimens: a contribution to the diagnosis of metabolic disorders with involvement of the nervous system.

Authors:  J J Martin; C Ceuterick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.